Literature DB >> 35614321

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute a simple solution.

Johannes Gratz1, Marion Wiegele1, Christoph Dibiasi1, Eva Schaden2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35614321     DOI： 10.1007/s00134-022-06744-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  4 in total

1.  Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic review.

Authors:  Annukka Vahtera; Suvi Vaara; Ville Pettilä; Anne Kuitunen
Journal:  Thromb Res       Date:  2016-01-04       Impact factor: 3.944

2.  VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis.

Authors:  Shannon M Fernando; Alexandre Tran; Wei Cheng; Behnam Sadeghirad; Yaseen M Arabi; Deborah J Cook; Morten Hylander Møller; Sangeeta Mehta; Robert A Fowler; Karen E A Burns; Philip S Wells; Marc Carrier; Mark A Crowther; Damon C Scales; Shane W English; Kwadwo Kyeremanteng; Salmaan Kanji; Michelle E Kho; Bram Rochwerg
Journal:  Chest       Date:  2021-08-19       Impact factor: 9.410

Review 3.  Challenging management dogma where evidence is non-existent, weak or outdated.

Authors:  Daniel A Hofmaenner; Mervyn Singer
Journal:  Intensive Care Med       Date:  2022-03-18       Impact factor: 41.787

4.  Trends and risk factors for omission of early thromboprophylaxis in Australian and New Zealand ICUs between 2009 and 2020.

Authors:  Berhe W Sahle; David Pilcher; Karlheinz Peter; James D McFadyen; Tracey Bucknall
Journal:  Intensive Care Med       Date:  2022-04-01       Impact factor: 41.787
  4 in total
  2 in total

1.  The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply.

Authors:  Daniel A Hofmaenner; Mervyn Singer
Journal:  Intensive Care Med       Date:  2022-06-17       Impact factor: 41.787

2.  Thromboprophylaxis in critical care.

Authors:  Julie Helms; Saskia Middeldorp; Alex C Spyropoulos
Journal:  Intensive Care Med       Date:  2022-08-29       Impact factor: 41.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.